↓ Skip to main content

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Overview of attention for article published in Journal of Clinical Oncology, June 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
2 news outlets
policy
4 policy sources
patent
11 patents

Citations

dimensions_citation
1174 Dimensions

Readers on

mendeley
373 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
Published in
Journal of Clinical Oncology, June 2006
DOI 10.1200/jco.2005.05.1003
Pubmed ID
Authors

Thomas M. Habermann, Edie A. Weller, Vicki A. Morrison, Randy D. Gascoyne, Peter A. Cassileth, Jeffrey B. Cohn, Shaker R. Dakhil, Bruce Woda, Richard I. Fisher, Bruce A. Peterson, Sandra J. Horning

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 373 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 2 <1%
Denmark 2 <1%
Brazil 2 <1%
Portugal 1 <1%
Canada 1 <1%
Peru 1 <1%
Malaysia 1 <1%
Taiwan 1 <1%
Sri Lanka 1 <1%
Other 2 <1%
Unknown 359 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 56 15%
Other 49 13%
Student > Bachelor 42 11%
Student > Ph. D. Student 40 11%
Student > Master 27 7%
Other 89 24%
Unknown 70 19%
Readers by discipline Count As %
Medicine and Dentistry 187 50%
Agricultural and Biological Sciences 32 9%
Biochemistry, Genetics and Molecular Biology 28 8%
Pharmacology, Toxicology and Pharmaceutical Science 11 3%
Nursing and Health Professions 6 2%
Other 27 7%
Unknown 82 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#1,242,689
of 25,837,817 outputs
Outputs from Journal of Clinical Oncology
#3,035
of 22,229 outputs
Outputs of similar age
#1,964
of 91,678 outputs
Outputs of similar age from Journal of Clinical Oncology
#10
of 156 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 91,678 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 156 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.